Medical News
|
Article ID: 700954 Mercy Medical Center, BaltimoreMercy Medical Center now offers the VenaSeal™ procedure as a new option for treating venous reflux disease and varicose veins. Released:21-Sep-2018 4:05 PM EDT |
|
Article ID: 700949 Ohio State UniversityResearchers around the world are exploring the gut/brain axis in the quest for knowledge about mood disorders such as depression, neurodegenerative diseases including Alzheimer’s and chronic conditions such as Crohn’s disease. Released:21-Sep-2018 4:05 PM EDT |
Embargo will expire:24-Sep-2018 3:00 PM EDTReleased to reporters:21-Sep-2018 3:45 PM EDT |
Article ID: 700939 Fight Colorectal CancerWith fall just around the corner, the Centers for Disease Control (CDC) expects flu season to begin ramping up within the next few months. Released:21-Sep-2018 3:30 PM EDTChannels: Immunology, Infectious Diseases, Vaccines, Influenza, Cancer |
Article ID: 700916 Albert Einstein College of MedicineDr. Chinazo Cunningham, M.D., M.S., a New York City-based expert in opioid use disorder will serve on a national board advising the CDC on best approaches to address the nation's opioid epidemic. Released:21-Sep-2018 3:30 PM EDT
EXPERT AVAILABLE
Channels: Addiction, Drugs and Drug Abuse, Substance Abuse, Local - New York, Local - New York Metro Opiods, Opioid Abuse Epidemic, opioid abuse solutions, opioid abuse prevention, opioid abuse, CDC, Centers for Disease Control & Prevention, National Center for Injury Prevention and Control, Opioid Addiction, Addiction, Overdose, overdose prevention |
Embargo will expire:24-Sep-2018 11:00 AM EDTReleased to reporters:21-Sep-2018 3:30 PM EDT |
|
Article ID: 700944 University of Alabama at BirminghamIn proof-of-concept experiments, researchers have highlighted a potential therapy for a rare but potentially deadly blood-clotting disorder, TTP. Researchers deliver a therapeutic enzyme via the cellular equivalent of a Trojan Horse, using platelets to protect the key enzyme hidden inside. Released:21-Sep-2018 3:30 PM EDT |
|
Article ID: 700947 Wayne State University Division of ResearchA research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma. Released:21-Sep-2018 3:30 PM EDT |
|
Article ID: 700932 Rensselaer Polytechnic Institute (RPI)Researchers at Rensselaer Polytechnic Institute—led by Juergen Hahn, professor and head of biomedical engineering—are continuing to make remarkable progress with their research focused on autism spectrum disorder (ASD). Released:21-Sep-2018 1:05 PM EDT |
Article ID: 700925 Mayo Clinicروتشستر، مينيسوتا - يعتبر مرض الانسداد الرئوي الزمن (COPD) بالنسبة لكثير من الناس مرضًا مؤلمًا ومتكررًا يؤثر على القدرة على التنفس وجودة الحياة. بالرغم من كون مرض الانسداد الرئوي المزمن مرضًا من الممكن علاجه، إلا أنه يبقى السبب الثالث المؤدي للوفاة في الولايات المتحدة الأمريكية. وفي الإصدار الأخير لمجلة Mayo Clinic Proceedings، يلقي الباحثون نظره فاحصه عن كثب على النتائج والتوصيات الجديدة للمبادرة العالمية لمرض الانسداد الرئوي المزمن (GOLD) لتقييم آخر التطورات والنظر في دور العلاج بالنسبة لهذا المرض. Released:21-Sep-2018 12:05 PM EDT |